Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir Effects on Cerebral Metabolism and Neurocognition in HCV
NCT02219685Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir, sofosbuvir in chronic hepatitis C (CHC), sponsored by Gilead Sciences. Started Aug 2014; status: completed.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT02219685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219685.